Načítá se...

Venetoclax-based Therapies for Acute Myeloid Leukemia

The prognosis of adult acute myeloid leukemia (AML) remains poor, with the long-term survival rate less than 50%. However, the current paradigms of treatment are changing through a better understanding of the disease genetics and pathophysiology. Since 2017, eight new drugs have been approved by the...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Best Pract Res Clin Haematol
Hlavní autoři: Guerra, Veronica A., DiNardo, Courtney, Konopleva, Marina
Médium: Artigo
Jazyk:Inglês
Vydáno: 2019
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6581210/
https://ncbi.nlm.nih.gov/pubmed/31203996
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.beha.2019.05.008
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!